Covid-19: Lancet piece warns of threat to doctors & paramedics
Friday, 20 March 2020 Of over 3,300 Covid-19 cases among health workers in China, 22 had died by the end of February, noted an editorial in the Lancet warning that unlike ventilators or wards, healthcare workers “cannot be urgently manufactured or run at 100% occupancy for long periods”. It called on governments to ensure the safety of healthcare workers as “health care workers are every country’s most valuable resources” in the current crisis.
The Director of All India Institute of Medical Science (AIIMS) in Delhi, Randeep Guleria said that COVID-19 cases are increasing in India because of the huge population. "The number of COVID19 cases is increasing in India because of the huge population of our country. But, we have a good recovery rate and the mortality rate is also very low," said Randeep Guleria to ANI.
The Governor of Goa, Satya Pal Malik on July 16 said that he had never said anything against media, Chief Minister Pramod Sawant has quoted him wrong. "I have never said anything against media. The truth is media is our strength. I got information from media, rather from the government. I called meeting on COVID situation on the base of media reports for correction, Chief Minister's statement is highly improper," said Satya Pal Malik while speaking to ANI. It is noted that Chief Minister of Goa, Pramod Sawant had quoted the Governor saying he is concerned about the negative and incorrect news. Sawant reportedly made this statement while speaking to reporters after a review meeting chaired by the Governor at the Raj Bhavan. The meeting was attended by CM Sawant, Health Minister Vishwajit Rane, Chief Secretary Parimal Rai and Health Secretary Nila Mohanan.
Council of Scientific and Industrial Research (CSIR), Director General Shekhar Mande said that WHO decision to halt trials of hydroxychloroquine for COVID-19 is not correct and it must resume as early as possible. "The study was published in Lancet on hydroxychloroquine and chloroquine and its effect on COVID-19. It is an observational study with statical parameters and analysis which is not sufficiently good. In our letter to the Lancet editor, we have written that the study design and statical interferences are not right therefore study does not deserve any attention of the readers. We believe that WHO's decision to temporarily halt the trials is not correct and demanded that the clinical trials of hydroxychloroquine for its use in COVID-19 cases must resume as early as possible," said Mande after WHO halts clinical trials of hydroxychloroquine for COVID-19.